Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Infectious Disease Immunoassay Testing Market Report 2016

  • QYR670142
  • 119 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Infectious Disease Immunoassay Testing

Revenue, means the sales value of Infectious Disease Immunoassay Testing

This report studies sales (consumption) of Infectious Disease Immunoassay Testing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Abbott Diagnostics

Alere Inc

Beckman Coulter, Inc. / Danaher

Becton, Dickinson and Company (BD)

bioMérieux Inc.

Bio-Rad Laboratories

Hologic

Instrumentation Laboratory (IL)

Ortho Clinical Diagnostics (OCD)

QIAGEN N.V

Roche Diagnostics

Siemens Healthineers

Sysmex Corporation

Thermo FisherScientific

Werfen Group S.A.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Infectious Disease Immunoassay Testing in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Infectious Disease Immunoassay Testing Market Report 2016

1 Infectious Disease Immunoassay Testing Overview

1.1 Product Overview and Scope of Infectious Disease Immunoassay Testing

1.2 Classification of Infectious Disease Immunoassay Testing

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Infectious Disease Immunoassay Testing

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Infectious Disease Immunoassay Testing (2011-2021)

1.4.1 United States Infectious Disease Immunoassay Testing Sales and Growth Rate (2011-2021)

1.4.2 United States Infectious Disease Immunoassay Testing Revenue and Growth Rate (2011-2021)

2 United States Infectious Disease Immunoassay Testing Competition by Manufacturers

2.1 United States Infectious Disease Immunoassay Testing Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Infectious Disease Immunoassay Testing Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Infectious Disease Immunoassay Testing Average Price by Manufactures (2015 and 2016)

2.4 Infectious Disease Immunoassay Testing Market Competitive Situation and Trends

2.4.1 Infectious Disease Immunoassay Testing Market Concentration Rate

2.4.2 Infectious Disease Immunoassay Testing Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Infectious Disease Immunoassay Testing Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Infectious Disease Immunoassay Testing Sales and Market Share by Type (2011-2016)

3.2 United States Infectious Disease Immunoassay Testing Revenue and Market Share by Type (2011-2016)

3.3 United States Infectious Disease Immunoassay Testing Price by Type (2011-2016)

3.4 United States Infectious Disease Immunoassay Testing Sales Growth Rate by Type (2011-2016)

4 United States Infectious Disease Immunoassay Testing Sales (Volume) by Application (2011-2016)

4.1 United States Infectious Disease Immunoassay Testing Sales and Market Share by Application (2011-2016)

4.2 United States Infectious Disease Immunoassay Testing Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Infectious Disease Immunoassay Testing Manufacturers Profiles/Analysis

5.1 Abbott Diagnostics

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Abbott Diagnostics Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Alere Inc

5.2.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Alere Inc Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Beckman Coulter, Inc. / Danaher

5.3.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Beckman Coulter, Inc. / Danaher Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Becton, Dickinson and Company (BD)

5.4.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Becton, Dickinson and Company (BD) Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 bioMérieux Inc.

5.5.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 bioMérieux Inc. Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Bio-Rad Laboratories

5.6.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Bio-Rad Laboratories Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Hologic

5.7.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Hologic Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Instrumentation Laboratory (IL)

5.8.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Instrumentation Laboratory (IL) Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Ortho Clinical Diagnostics (OCD)

5.9.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Ortho Clinical Diagnostics (OCD) Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 QIAGEN N.V

5.10.2 Infectious Disease Immunoassay Testing Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 QIAGEN N.V Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Roche Diagnostics

5.12 Siemens Healthineers

5.13 Sysmex Corporation

5.14 Thermo FisherScientific

5.15 Werfen Group S.A.

6 Infectious Disease Immunoassay Testing Manufacturing Cost Analysis

6.1 Infectious Disease Immunoassay Testing Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Infectious Disease Immunoassay Testing

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Infectious Disease Immunoassay Testing Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Infectious Disease Immunoassay Testing Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Infectious Disease Immunoassay Testing Market Forecast (2016-2021)

10.1 United States Infectious Disease Immunoassay Testing Sales, Revenue Forecast (2016-2021)

10.2 United States Infectious Disease Immunoassay Testing Sales Forecast by Type (2016-2021)

10.3 United States Infectious Disease Immunoassay Testing Sales Forecast by Application (2016-2021)

10.4 Infectious Disease Immunoassay Testing Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Infectious Disease Immunoassay Testing

Table Classification of Infectious Disease Immunoassay Testing

Figure United States Sales Market Share of Infectious Disease Immunoassay Testing by Type in 2015

Table Application of Infectious Disease Immunoassay Testing

Figure United States Sales Market Share of Infectious Disease Immunoassay Testing by Application in 2015

Figure United States Infectious Disease Immunoassay Testing Sales and Growth Rate (2011-2021)

Figure United States Infectious Disease Immunoassay Testing Revenue and Growth Rate (2011-2021)

Table United States Infectious Disease Immunoassay Testing Sales of Key Manufacturers (2015 and 2016)

Table United States Infectious Disease Immunoassay Testing Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Infectious Disease Immunoassay Testing Sales Share by Manufacturers

Figure 2016 Infectious Disease Immunoassay Testing Sales Share by Manufacturers

Table United States Infectious Disease Immunoassay Testing Revenue by Manufacturers (2015 and 2016)

Table United States Infectious Disease Immunoassay Testing Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Infectious Disease Immunoassay Testing Revenue Share by Manufacturers

Table 2016 United States Infectious Disease Immunoassay Testing Revenue Share by Manufacturers

Table United States Market Infectious Disease Immunoassay Testing Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Infectious Disease Immunoassay Testing Average Price of Key Manufacturers in 2015

Figure Infectious Disease Immunoassay Testing Market Share of Top 3 Manufacturers

Figure Infectious Disease Immunoassay Testing Market Share of Top 5 Manufacturers

Table United States Infectious Disease Immunoassay Testing Sales by Type (2011-2016)

Table United States Infectious Disease Immunoassay Testing Sales Share by Type (2011-2016)

Figure United States Infectious Disease Immunoassay Testing Sales Market Share by Type in 2015

Table United States Infectious Disease Immunoassay Testing Revenue and Market Share by Type (2011-2016)

Table United States Infectious Disease Immunoassay Testing Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Infectious Disease Immunoassay Testing by Type (2011-2016)

Table United States Infectious Disease Immunoassay Testing Price by Type (2011-2016)

Figure United States Infectious Disease Immunoassay Testing Sales Growth Rate by Type (2011-2016)

Table United States Infectious Disease Immunoassay Testing Sales by Application (2011-2016)

Table United States Infectious Disease Immunoassay Testing Sales Market Share by Application (2011-2016)

Figure United States Infectious Disease Immunoassay Testing Sales Market Share by Application in 2015

Table United States Infectious Disease Immunoassay Testing Sales Growth Rate by Application (2011-2016)

Figure United States Infectious Disease Immunoassay Testing Sales Growth Rate by Application (2011-2016)

Table Abbott Diagnostics Basic Information List

Table Abbott Diagnostics Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Diagnostics Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Alere Inc Basic Information List

Table Alere Inc Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alere Inc Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Beckman Coulter, Inc. / Danaher Basic Information List

Table Beckman Coulter, Inc. / Danaher Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Beckman Coulter, Inc. / Danaher Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Becton, Dickinson and Company (BD) Basic Information List

Table Becton, Dickinson and Company (BD) Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Becton, Dickinson and Company (BD) Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table bioMérieux Inc. Basic Information List

Table bioMérieux Inc. Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table bioMérieux Inc. Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Bio-Rad Laboratories Basic Information List

Table Bio-Rad Laboratories Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bio-Rad Laboratories Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Hologic Basic Information List

Table Hologic Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hologic Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Instrumentation Laboratory (IL) Basic Information List

Table Instrumentation Laboratory (IL) Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Instrumentation Laboratory (IL) Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Ortho Clinical Diagnostics (OCD) Basic Information List

Table Ortho Clinical Diagnostics (OCD) Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ortho Clinical Diagnostics (OCD) Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table QIAGEN N.V Basic Information List

Table QIAGEN N.V Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table QIAGEN N.V Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Roche Diagnostics Basic Information List

Table Roche Diagnostics Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Diagnostics Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Siemens Healthineers Basic Information List

Table Siemens Healthineers Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Siemens Healthineers Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Sysmex Corporation Basic Information List

Table Sysmex Corporation Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sysmex Corporation Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Thermo FisherScientific Basic Information List

Table Thermo FisherScientific Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Thermo FisherScientific Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Werfen Group S.A. Basic Information List

Table Werfen Group S.A. Infectious Disease Immunoassay Testing Sales, Revenue, Price and Gross Margin (2011-2016)

Table Werfen Group S.A. Infectious Disease Immunoassay Testing Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Infectious Disease Immunoassay Testing

Figure Manufacturing Process Analysis of Infectious Disease Immunoassay Testing

Figure Infectious Disease Immunoassay Testing Industrial Chain Analysis

Table Raw Materials Sources of Infectious Disease Immunoassay Testing Major Manufacturers in 2015

Table Major Buyers of Infectious Disease Immunoassay Testing

Table Distributors/Traders List

Figure United States Infectious Disease Immunoassay Testing Production and Growth Rate Forecast (2016-2021)

Figure United States Infectious Disease Immunoassay Testing Revenue and Growth Rate Forecast (2016-2021)

Table United States Infectious Disease Immunoassay Testing Production Forecast by Type (2016-2021)

Table United States Infectious Disease Immunoassay Testing Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390